Health
Vaccine startup Curevo takes on pharma giant GSK, raises $60M for trial of shingles shot
Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the chickenpox virus. The …
Curevo has raised $60 million to develop a new vaccine for shingles, an often-painful condition caused by reactivation of the chickenpox virus. The …
